Drug Trial Radar · NCT07422480
A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Lower Risk Myelodysplastic Syndromes (LR-MDS) Who Need Regular Blood Transfusions
Last checked: Nov 19, 2026Latest source record: Nov 6, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
300
Planned (sponsor's estimate)
Start
May 21, 2026
Primary completion
Apr 30, 2029
Study completion Oct 1, 2033
Sponsor
- Lead sponsor
- TakedaTakeda (TAK)
- Sponsor type
- Industry
- First posted
- Feb 20, 2026
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The main aim of this study is to assess how much elritercept reduces the need for RBC (red blood cell) transfusions and improves hemoglobin blood values in addition to how safe elritercept is when compared with epoetin alfa. Other key aims are to learn how much elritercept improves tiredness and quality of life as reported by participants compared with epoetin alfa; to assess what risks (side effects) and how often they occur with elritercept compared with epoetin alfa. The study will also collect information for researchers to see how the disease in the bone marrow or other body areas may be affected by elritercept compared with epoetin alfa to try to learn how to better treat this disease.
Conditions
- Myelodysplastic Syndrome
- Anemia
Interventions
ElriterceptDrug
Elritercept, SC injection.
Epoetin AlfaDrug
Epoetin Alfa, SC injection.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Proportion of Participants who are RBC Transfusion Independent (RBC-TI) for any Consecutive Greater Than Equal to (≥) 12-Week Period From Day 1 Through 24 Weeks With Concurrent Mean Hemoglobin (Hgb) Increase ≥ 1.5 Grams per Deciliter (g/dL) From BaselineTime frame: From Cycle 1 Day 1 through Week 24 (each cycle is 28 days)
Locations
166 sites in 28 countries. Site status is shown where the registry gives one.
Banner MD Anderson Cancer Center
Gilbert, Arizona · Not yet recruiting
City of Hope - Comprehensive Cancer Center (CCC)
Duarte, California · Not yet recruiting
Providence Medical Group
Santa Rosa, California · Not yet recruiting
Cancer & Blood Research Center
Whittier, California · Not yet recruiting
Yale
New Haven, Connecticut · Not yet recruiting
Florida Oncology & Hematology
Fort Myers, Florida · Not yet recruiting
University of Miami
Miami, Florida · Not yet recruiting
BRCR Medical Center Inc
Tamarac, Florida · Recruiting
Moffitt Cancer Center
Tampa, Florida · Not yet recruiting
Emory University
Atlanta, Georgia · Recruiting
Saint Luke's Cancer Institute
Boise, Idaho · Not yet recruiting
Orchard Healthcare Research Inc. (OHR) - Skokie
Skokie, Illinois · Recruiting
Norton Cancer Institute
Louisville, Kentucky · Recruiting
Epic Medical Research
Monroe, Louisiana · Not yet recruiting
Epic Medical Research - Shreveport
Shreveport, Louisiana · Not yet recruiting
The Cancer and Hematology Centers
Grand Rapids, Michigan · Not yet recruiting
American Oncology Partners P.A. MidAmerica Cancer Care
Kansas City, Missouri · Recruiting
Icahn School of Medicine at Mount Sinai
New York, New York · Not yet recruiting
Hematology Oncology Associates of Rockland
Nyack, New York · Not yet recruiting
UR Medicine (University of Rochester Medical Center)
Rochester, New York · Not yet recruiting
Albert Einstein College - Montefiore
The Bronx, New York · Recruiting
Novant Health Care Institute
Winston-Salem, North Carolina · Not yet recruiting
Cleveland clinic OH
Cleveland, Ohio · Not yet recruiting
Thomas Jefferson University
Philadelphia, Pennsylvania · Not yet recruiting
Fox Chase Cancer Center
Philadelphia, Pennsylvania · Recruiting
Tennessee Oncology, PLLC
Nashville, Tennessee · Recruiting
World Research Link
Baytown, Texas · Recruiting
Texas Oncology - Denton
Denton, Texas · Recruiting
The Center for Cancer and Blood Disorders
Fort Worth, Texas · Recruiting
The University of Texas-MD Anderson Cancer Center - Leukemia Center
Houston, Texas · Recruiting
LUMI Research
Houston, Texas · Recruiting
Renovatio Clinical
The Woodlands, Texas · Recruiting
Huntsman Cancer Institute
Salt Lake City, Utah · Not yet recruiting
Virginia Commonwealth University (VCU)-Medical Center - North Hospital
Richmond, Virginia · Not yet recruiting
West Virginia University Cancer Institute
Wheeling, West Virginia · Recruiting
Swiss Medical Center - Barrio Parque
Buenos Aires, Argentina · Recruiting
Sanatorio Allende S.A. - Nueva Cordoba
Córdoba, Argentina · Not yet recruiting
Hospital Privado de Cordoba
Córdoba, Argentina · Recruiting
Instituto Medico de la Fundacion Estudios Clinicos
Rosario, Santa Fe Province, Argentina · Recruiting
Mid North Coast Local Health District - Mid North Coast Cancer Institute (MNCCI) - Coffs Harbour
Coffs Harbour, New South Wales, Australia · Not yet recruiting
Showing 40 of 166 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.